Acute kidney injury (AKI) is a common clinical syndrome in hospitalized patients and is associated with increased morbidity, mortality, and cost of care.
1-3 Consensus criteria define AKI by either an increase in serum creatinine (SCr) concentration or a decrease in urine output.
4 Biomarkers that detect AKI prior to these changes have been investigated for several years. However, to date, there has been limited large-scale validation and implementation of these tools. Detection of AKI prior to the changes in SCr concentration may provide a crucial window of opportunity to prevent further injury and allow clinicians to intervene in the hopes of improving patient outcomes.